senicapoc: Clinical Trials

2 trials of senicapoc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Terminated 2

Follow senicapoc: new trials by email Literature Review of senicapoc trials Research Report on senicapoc

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea Therapy
ICA-17043 - Sickle Cell Disease, Sickle Cell Anemia
Phase 3TerminatedIcagen512006-02-012007-09-11
A Stratified Sickle Event Randomized Trial (ASSERT)
ICA-17043 - Sickle Cell Disease
Phase 3TerminatedIcagen2972005-02-012008-03-27

Conditions studied

Anemia, Sickle Cell (2)

Sponsors

Icagen (2)

Countries

United States (2)  ·  Brazil (1)  ·  France (1)  ·  Jamaica (1)  ·  Trinidad and Tobago (1)  ·  United Kingdom (1)

Top investigators

Jonathan W Stocker, Ph.D. (1)  ·  Jonathan W Stocker, PhD (1)